Larimar Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Larimar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Larimar Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Larimar Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $229k | 71k | 3.23 |
| 2025-06-30 | $246k | 85k | 2.89 |
| 2025-03-31 | $116k | 54k | 2.14 |
| 2024-12-31 | $273k | 70k | 3.88 |
| 2024-09-30 | $393k | 60k | 6.55 |
| 2024-06-30 | $104k | 14k | 7.30 |
| 2024-03-31 | $138k | 18k | 7.58 |
| 2023-12-31 | $160k | 35k | 4.53 |
| 2023-09-30 | $20k | 5.0k | 3.98 |
| 2023-06-30 | $170k | 54k | 3.13 |
| 2023-03-31 | $128k | 28k | 4.52 |